Atención odontológica en pacientes con cirrosis hepática, una praxis que necesita ser considerada
DOI:
https://doi.org/10.61154/holopraxis.v7i2.3309Palabras clave:
Microbiota; cavidad oral; cirrosis hepática; odontología; hepatotóxicoResumen
El ecosistema de la cavidad oral es abierto y dinámico con factores que condicionan su composición y que continuamente se expone a modificaciones que afectan las características intrínsecas del microbiota bucal dando lugar a la sustitución de los microorganismos; teniendo una relación directa e indirecta con tejidos y órganos distantes de manera bidireccional. A la fecha, el efecto sistémico, clínico y microbiológico de la cavidad oral y la enfermedad hepática crónica no ha sido del todo descrita. El objetivo de este artículo fue exponer la importancia del estado de salud hepático en pacientes de la consulta odontológica, con la finalidad de realizar los procedimientos y tratamientos odontológico-adecuados. Como estrategia metodológica se realizó un estudio descriptivo a partir de una búsqueda sistematizada del acervo bibliográfico disponible en MEDLINE/PubMed, SCOPUS, ISI web Knowledge, IME), sin restricción de fecha de publicación. Este análisis arrojó como resultado que la cirrosis hepática como condición sistémica, su efecto y correlación con la cavidad oral a nivel clínico y microbiológico es poco considerada durante la atención odontológica. Por lo cual, se concluyó que es fundamental realizar un cuestionamiento dirigido a los pacientes que acuden a atención odontológica respecto al estado de salud hepático con la intención de tener una buena praxis clínica de estos pacientesDescargas
Citas
Aberg, F., & Helenius-Hietala, J. (2022). Oral Health and Liver Disease: Bidirectional Associations-A Narrative Review. Dent J (Basel), 10(2). doi:10.3390/dj10020016
Acharya, C., Sahingur, S. E., & Bajaj, J. S. (2017). Microbiota, cirrhosis, and the emerging oral-gut-liver axis. Jci Insight, 2(19). doi:10.1172/jci.insight.94416
Adachi, M., Sakamoto, H., Kawamura, R., Wang, W., Imai, K., & Shinomura, Y. (2007). Nonsteroidal anti-inflammatory drugs and oxidative stress in cancer cells. Histology and Histopathology, 22(4), 437-442.
Addolorato, G., Vassallo, G. A., Mirijello, A., & Gasbarrini, A. (2019). Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows. Neurotherapeutics 2019 17:1, 17, 127-141. doi:10.1007/S13311-019-00802-8
Al-Odayni, A. B., Alfotawi, R., Khan, R., Sharaf Saeed, W., Al-Kahtani, A., Aouak, T., & Alrahlah, A. (2019). Synthesis of chemically modified BisGMA analog with low viscosity and potential physical and biological properties for dental resin composite. Dent Mater, 35(11), 1532-1544. doi:10.1016/j.dental.2019.07.013
Alukal, J. J., & Thuluvath, P. J. (2019). Reversal of NASH fibrosis with pharmacotherapy. Hepatology international, 13(5), 534-545. doi:10.1007/s12072-019-09970-3
Asaad, T., & Samdani, A. J. (2005). Association of lichen planus with hepatitis C virus infection. Ann Saudi Med, 25(3), 243-246. doi:10.5144p/0256-4947.2005.243
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019). Burden of liver diseases in the world. J Hepatol, 70(1), 151-171. doi:10.1016/j.jhep.2018.09.014
Atzori, L., Poli, G., & Perra, A. (2009). Hepatic stellate cell: a star cell in the liver. Int J Biochem Cell Biol, 41(8-9), 1639-1642. doi:10.1016/j.biocel.2009.03.001
Bajaj, J. S., Matin, P., White, M. B., Fagan, A., Deeb, J. G., Acharya, C., . . . Sahingur, S. E. (2018). Periodontal therapy favorably modulates the oral-gut-hepatic axis in cirrhosis. Am J Physiol Gastrointest Liver Physiol, 315(5), G824-G837. doi:10.1152/ajpgi.00230.2018
Barbaresso, R. C., Rau, I., Zgarian, R. G., Meghea, A., & Ghica, M. V. (2014). Niflumic acid-collagen delivery systems used as anti-inflammatory drugs and analgesics in dentistry. Comptes Rendus Chimie, 17(1), 12-17. doi:10.1016/j.crci.2013.07.007
Barbier, O., Arreola-Mendoza, L., & Del Razo, L. M. (2010). Molecular mechanisms of fluoride toxicity. Chem Biol Interact, 188(2), 319-333. doi:10.1016/j.cbi.2010.07.011
Bataller, R., & Gao, B. (2015). Liver Fibrosis in Alcoholic Liver Disease. Seminars in Liver Disease, 35, 146-156. doi:10.1055/S-0035-1550054
Bi, H. J., Ming, L. G., Cheng, R. P., Luo, H. L., Zhang, Y. J., & Jin, Y. (2017). Liver extracellular matrix promotes BM-MSCs hepatic differentiation and reversal of liver fibrosis through activation of integrin pathway. Journal of Tissue Engineering and Regenerative Medicine, 11(10), 2685-2698. doi:10.1002/term.2161
Bjornsson, E. S. (2020). Epidemiology, Predisposing Factors, and Outcomes of Drug-Induced Liver Injury. Clin Liver Dis, 24(1), 1-10. doi:10.1016/j.cld.2019.08.002
Bradley, K. A., Debenedetti, A. F., Volk, R. J., Williams, E. C., Frank, D., & Kivlahan, D. R. (2007). AUDIT-C as a brief screen for alcohol misuse in primary care. Alcoholism, clinical and experimental research, 31, 1208-1217. doi:10.1111/J.1530-0277.2007.00403.X
Campos-Varela, I., & Castells, L. (2008). Puntuaciones de pronóstico de la cirrosis. Gastroenterología y Hepatología, 31, 439-446. doi:10.1157/13125591
Cheema, B., Hyachwan, K., Markert, R. J., Triplett, D., & Krishnamurthy, P. (2020). Impact of Hepatitis C Treatment With Direct-Acting Antiviral Agents on Liver Stiffness Using Vibration-Controlled Transient Elastography and Fibrosis-4 Scores: A Prospective Study in the US Veteran Population. American Journal of Gastroenterology, 115, S537-S537.
Chen, L. Y., Yang, P. C., Hu, L. L., Yang, L., Chu, H. K., & Hou, X. H. (2023). Modulating phenylalanine metabolism by L. acidophilus alleviates alcohol-related liver disease through enhancing intestinal barrier function. Cell and Bioscience, 13(1). doi:10.1186/S13578-023-00974-Z
Contaldo, M., Fusco, A., Stiuso, P., Lama, S., Gravina, A. G., Itro, A., . . . Donnarumma, G. (2021). Oral Microbiota and Salivary Levels of Oral Pathogens in Gastro-Intestinal Diseases: Current Knowledge and Exploratory Study. Microorganisms, 9(5). doi:10.3390/microorganisms9051064
Dunn, W., & Shah, V. H. (2016). Pathogenesis of Alcoholic Liver Disease. Clinics in Liver Disease, 20, 445. doi:10.1016/J.CLD.2016.02.004
El-Naggar, S. A., El-Said, K. S., Elwan, M., Mobasher, M., Mansour, F., Elbakry, M., & Kabil, D. I. (2020). Toxicity of bean cooking media containing EDTA in mice. Toxicol Ind Health, 36(6), 436-445. doi:10.1177/0748233719893178
European Association for the Study of the Liver. Electronic address, e. e. e., & European Association for the Study of the, L. (2018). Corrigendum to "EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis" [J Hepatol 69 (2018) 406-460]. J Hepatol, 69(5), 1207. doi:10.1016/j.jhep.2018.08.009
Georgescu, S. R., Tampa, M., Mitran, M. I., Mitran, C. I., Sarbu, M. I., Nicolae, I., . . . Popa, M. I. (2019). Potential pathogenic mechanisms involved in the association between lichen planus and hepatitis C virus infection. Exp Ther Med, 17(2), 1045-1051. doi:10.3892/etm.2018.6987
Golla, K., Epstein, J. B., & Cabay, R. J. (2004). Liver disease: current perspectives on medical and dental management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 98(5), 516-521. doi:10.1016/S1079210404006432
Gressner, O. A., Weiskirchen, R., & Gressner, A. M. (2007). Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests. Clin Chim Acta, 381(2), 107-113. doi:10.1016/j.cca.2007.02.038
Gronkjaer, L. L. (2015). Periodontal disease and liver cirrhosis: A systematic review. SAGE Open Med, 3, 2050312115601122. doi:10.1177/2050312115601122
Gursoy, U. K., Gursoy, M., Liukkonen, A., Suominen, A. L., & Kononen, E. (2023). Salivary Human beta-Defensin 1-3 and Human alpha-Defensin-1 Levels in Relation to the Extent of Periodontal Disease and Tooth Loss in the Elderly. Journal of Clinical Medicine, 12(3). doi:10.3390/Jcm12030976
Gutierrez-Reyes, G., Gutierrez-Ruiz, M. C., & Kershenobich, D. (2007). Liver fibrosis and chronic viral hepatitis. Arch Med Res, 38(6), 644-651. doi:10.1016/j.arcmed.2006.10.001
Hicks, J. L. (2015). Oral care of the patient with liver failure, pretransplant--a retrospective study. Spec Care Dentist, 35(1), 8-14. doi:10.1111/scd.12075
Higashi, T., Friedman, S. L., & Hoshida, Y. (2017). Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev, 121, 27-42. doi:10.1016/j.addr.2017.05.007
Higuera-de-la-Tijera, F., Lira-Vera, J. E., Morales-Gutierrez, O., Martinez-Castillo, M., Medina-Avila, Z., Servin-Caamano, A., . . . Gutierrez-Reyes, G. (2022). Alcoholic Liver Disease. Clin Liver Dis (Hoboken), 19(2), 63-67. doi:10.1002/cld.1164
Hosseini, N., Shor, J., & Szabo, G. (2019). Alcoholic Hepatitis: A Review. Alcohol Alcohol, 54(4), 408-416. doi:10.1093/alcalc/agz036
INEGI. (2022). Comunicado de prensa 24/22. Instituto Nacional de Estadística y Geografía., 1-40.
Kawaratani, H., Tsujimoto, T., Douhara, A., Takaya, H., Moriya, K., Namisaki, T., . . . Fukui, H. (2013). The effect of inflammatory cytokines in alcoholic liver disease. Mediators of Inflammation, 2013. doi:10.1155/2013/495156
Khor, B., Snow, M., Herrman, E., Ray, N., Mansukhani, K., Patel, K. A., . . . Machida, C. A. (2021). Interconnections between the Oral and Gut Microbiomes: Reversal of Microbial Dysbiosis and the Balance between Systemic Health and Disease. Microorganisms, 9(3). doi:10.3390/microorganisms9030496
Kinane, D. F., Stathopoulou, P. G., & Papapanou, P. N. (2017). Periodontal diseases. Nature Reviews Disease Primers, 3. doi:10.1038/Nrdp.2017.38
Kuscuoglu, D., Janciauskiene, S., Hamesch, K., Haybaeck, J., Trautwein, C., & Strnad, P. (2018). Liver - master and servant of serum proteome. J Hepatol, 69(2), 512-524. doi:10.1016/j.jhep.2018.04.018
Ladegaard Gronkjaer, L., Holmstrup, P., Jepsen, P., & Vilstrup, H. (2021). The impact of oral diseases in cirrhosis on complications and mortality. JGH Open, 5(2), 294-300. doi:10.1002/jgh3.12489
Lemmers, A., Moreno, C., Gustot, T., Maréchal, R., Degré, D., Demetter, P., . . . Devière, J. (2009). The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology, 49, 646-657. doi:10.1002/HEP.22680
Lino, P. A., Sohn, W., Singhal, A., Martins, M. A. P., Silva, M. E. D. E., & de Abreu, M. H. N. G. (2019). A national study on the use of opioid analgesics in dentistry. Brazilian Oral Research, 33. doi:10.1590/1807-3107bor-2019.vol33.0076
Lucena, M. I., Sanabria, J., Garcia-Cortes, M., Stephens, C., & Andrade, R. J. (2020). Drug-induced liver injury in older people. Lancet Gastroenterol Hepatol, 5(9), 862-874. doi:10.1016/S2468-1253(20)30006-6
Marcellin, P., Asselah, T., & Boyer, N. (2002). Fibrosis and disease progression in hepatitis C. Hepatology, 36, s47-s56. doi:10.1053/JHEP.2002.36993
Martinez-Castillo, M., Altamirano-Mendoza, I., Sanchez-Valle, S., Garcia-Islas, L., Sanchez-Barragan, M., Hernandez-Santillan, M., . . . Gutierrez-Reyes, G. (2023). Immune dysregulation and pathophysiology of alcohol consumption and alcoholic liver disease. Rev Gastroenterol Mex (Engl Ed), 88(2), 136-154. doi:10.1016/j.rgmxen.2023.03.003
Martinez-Castillo, M., Altamirano-Mendoza, I., Zielinski, R., Priebe, W., Pina-Barba, C., & Gutierrez-Reyes, G. (2023). Collagen matrix scaffolds: Future perspectives for the management of chronic liver diseases. World J Clin Cases, 11(6), 1224-1235. doi:10.12998/wjcc.v11.i6.1224
Martinez-Castillo, M., Hernandez-Barragan, A., Flores-Vasconcelos, I., Galicia-Moreno, M., Rosique-Oramas, D., Perez-Hernandez, J. L., . . . Gutierrez-Reyes, G. (2021). Production and activity of matrix metalloproteinases during liver fibrosis progression of chronic hepatitis C patients. World Journal of Hepatology, 13(2), 218-232. doi:10.4254/wjh.v13.i2.218
Martinez-Castillo, M., Rosique-Oramas, D., Medina-Avila, Z., Perez-Hernandez, J. L., Higuera-De la Tijera, F., Santana-Vargas, D., . . . Gutierrez-Reyes, G. (2020). Differential production of insulin-like growth factor-binding proteins in liver fibrosis progression. Molecular and Cellular Biochemistry, 469(1-2), 65-75. doi:10.1007/s11010-020-03728-4
Mendez-Sanchez, N., Villa, A. R., Chavez-Tapia, N. C., Ponciano-Rodriguez, G., Almeda-Valdes, P., Gonzalez, D., & Uribe, M. (2005). Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol, 4(1), 52-55.
Movin, S. (1981). Relationship between periodontal disease and cirrhosis of the liver in humans. J Clin Periodontol, 8(6), 450-458. doi:10.1111/j.1600-051x.1981.tb00894.x
Nagasaki, A., Sakamoto, S., Arai, T., Kato, M., Ishida, E., Furusho, H., . . . Miyauchi, M. (2021). Elimination of Porphyromonas gingivalis inhibits liver fibrosis and inflammation in NASH. J Clin Periodontol, 48(10), 1367-1378. doi:10.1111/jcpe.13523
Novacek, G., Plachetzky, U., Potzi, R., Lentner, S., Slavicek, R., Gangl, A., & Ferenci, P. (1995). Dental and periodontal disease in patients with cirrhosis--role of etiology of liver disease. J Hepatol, 22(5), 576-582. doi:10.1016/0168-8278(95)80453-6
Nusrat, F., Rahman, M. T., & Karim, M. M. (2023). Bacterial endotoxins in periodontal health and diseases. Biocell, 47(1), 81-89. doi:10.32604/biocell.2023.024635
Oleaga, J. M., Gardeazabal, J., Sanz de Galdeano, C., & Diaz, P. J. (1995). Generalized lichen planus associated with primary biliar cirrhosis which resolved after liver transplantation. Acta Derm Venereol, 75(1), 87. doi:10.2340/000155557587
Onder, C., Kurgan, S., Altingoz, S. M., Bagis, N., Uyanik, M., Serdar, M. A., . . . Gunhan, M. (2017). Impact of non-surgical periodontal therapy on saliva and serum levels of markers of oxidative stress. Clin Oral Investig, 21(6), 1961-1969. doi:10.1007/s00784-016-1984-z
Osna, N. A., Donohue, T. M., Jr., & Kharbanda, K. K. (2017). Alcoholic Liver Disease: Pathogenesis and Current Management. Alcohol Res, 38(2), 147-161.
Paik, J. M., Golabi, P., Younossi, Y., Mishra, A., & Younossi, Z. M. (2020). Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD. Hepatology, 72(5), 1605-1616. doi:10.1002/hep.31173
Peck, B., Workeneh, B., Kadikoy, H., Patel, S. J., & Abdellatif, A. (2011). Spectrum of sodium hypochlorite toxicity in man-also a concern for nephrologists. NDT Plus, 4(4), 231-235. doi:10.1093/ndtplus/sfr053
Peng, Y., Qi, X., & Guo, X. (2016). Child-Pugh Versus MELD Score for the Assessment of Prognosis in Liver Cirrhosis: A Systematic Review and Meta-Analysis of Observational Studies. Medicine (Baltimore), 95(8), e2877. doi:10.1097/MD.0000000000002877
Reitano, E., de'Angelis, N., Gavriilidis, P., Gaiani, F., Memeo, R., Inchingolo, R., . . . Carra, M. C. (2021). Oral Bacterial Microbiota in Digestive Cancer Patients: A Systematic Review. Microorganisms, 9(12). doi:10.3390/microorganisms9122585
Rincic, G., Gacina, P., Jukic, L. V., Rincic, N., Bozic, D., & Badovinac, A. (2021). Association between Periodontitis and Liver Disease. Acta Clinica Croatica, 60(3), 510-518. doi:10.20471/acc.2021.60.03.22
Rodriguez Martinez, S., Talavan Serna, J., & Silvestre, F. J. (2016). [Dental management in patients with cirrhosis]. Gastroenterol Hepatol, 39(3), 224-232. doi:10.1016/j.gastrohep.2015.07.005
Seki, E., Park, E., & Fujimoto, J. (2011). Toll-like receptor signaling in liver regeneration, fibrosis and carcinogenesis. Hepatology Research, 41(7), 597-610. doi:10.1111/j.1872-034X.2011.00822.x
Senel, S. (2021). An Overview of Physical, Microbiological and Immune Barriers of Oral Mucosa. Int J Mol Sci, 22(15). doi:10.3390/Ijms22157821
Suh, J. I. (2020). Drug-induced liver injury. Yeungnam Univ J Med, 37(1), 2-12. doi:10.12701/yujm.2019.00297
Sultan, A. R., Hoppenbrouwers, T., Lemmens-den Toom, N. A., Snijders, S. V., van Neck, J. W., Verbon, A., . . . van Wamel, W. J. B. (2019). During the Early Stages of Staphylococcus aureus Biofilm Formation, Induced Neutrophil Extracellular Traps Are Degraded by Autologous Thermonuclease. Infection and Immunity, 87(12). doi:10.1128/IAI.00605-19
Szabo, G., Mitchell, M. C., McClain, C. J., Dasarathy, S., McCullough, A. J., Nagy, L., . . . Barton, B. (2018). IL-1 Receptor Antagonist in Combination with Pentoxifylline and Zinc for Severe Alcoholic Hepatitis: A Multicenter Randomized Double-Bind Placebo-Controlled Clinical Trial. Hepatology, 68(6), 1445a-1445a.
Tavakoli, H. R., Hull, M., & Okasinski, L. M. (2011). Review of Current Clinical Biomarkers for the Detection of Alcohol Dependence. Innovations in Clinical Neuroscience, 8, 26.
Thomas, C., Minty, M., Canceill, T., Loubieres, P., Azalbert, V., Terce, F., . . . Blasco-Baque, V. (2021). Obesity Drives an Oral Microbiota Signature of Female Patients with Periodontitis: A Pilot Study. Diagnostics (Basel), 11(5). doi:10.3390/diagnostics11050745
Tungland, B. (2018). Oral Dysbiosis and Periodontal Disease: Effects on Systemic Physiology and in Metabolic Diseases, and Effects of Various Therapeutic Strategies. Human Microbiota in Health and Disease: Pathogenesis to Therapy, 421-461. doi:10.1016/B978-0-12-814649-1.00010-7
Vanoli, J., Nava, M., Invernizzi, C., Panizzuti, F., & Grassi, G. (2022). Metronidazole-induced hepatotoxicity in a patient with xeroderma pigmentosum: A case report. Medicine (Baltimore), 101(21), e29416. doi:10.1097/MD.0000000000029416
Verma, D., Garg, P. K., & Dubey, A. K. (2018). Insights into the human oral microbiome. Archives of Microbiology, 200(4), 525-540. doi:10.1007/s00203-018-1505-3
Yao, C., Lan, D. M., Li, X., Wang, Y., Qi, S. C., & Liu, Y. H. (2023). Porphyromonas gingivalis is a risk factor for the development of nonalcoholic fatty liver disease via ferroptosis. Microbes and Infection, 25(1-2). doi:10.1016/J.Micinf.2022.105040
Yoneda, M., Naka, S., Nakano, K., Wada, K., Endo, H., Mawatari, H., . . . Nakajima, A. (2012). Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. Bmc Gastroenterology, 12, 16. doi:10.1186/1471-230X-12-16
Zhou, M., Wu, R., Dong, W., Jacob, A., & Wang, P. (2008). Endotoxin downregulates peroxisome proliferator-activated receptor-γ via the increase in TNF-α release. https://doi.org/10.1152/ajpregu.00340.2007, 294, 84-92. doi:10.1152/AJPREGU.00340.2007
Zychowska, M. (2020). No evidence for association between cutaneous lichen planus and hepatitis B and C virus infection in south Poland - a case-control study. Int J Dermatol, 59(6), 698-703. doi:10.1111/ijd.14880
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Ingrid Viridiana Hernández-González, Moisés Martínez Castillo , Gabriela Gutiérrez Reyes, Lía Alioth Hoz Rodríguez
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH URL: https://revista.uniandes.edu.ec/ojs/index.php/holopraxis/oai
